NJ State Employees Deferred Compensation Plan’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $54.4K | Hold |
|
|||||
|
2024
Q3 | $92.9K | Hold |
|
|||||
|
2024
Q2 | $46K | Hold |
|
|||||
|
2024
Q1 | $88.1K | Hold |
|
|||||
|
2023
Q4 | $157K | Hold |
|
|||||
|
2023
Q3 | $205K | Hold |
|
|||||
|
2023
Q2 | $453K | Hold |
|
|||||
|
2023
Q1 | $577K | Hold |
|
|||||
|
2022
Q4 | $330K | Hold |
|
|||||
|
2022
Q3 | $483K | Buy |
|